An interactive lineage of chronic lymphocytic leukemia / small lymphocytic lymphoma drug development for hematologist-oncologists. Trace each agent's Phase 1 → 3 → regulatory arc, the pivotal trials behind every label, and the parallel del(17p)/TP53 thread that displaced allo-SCT. Endpoints throughout: PFS, OS, ORR, CR/PR, uMRD undetectability, TTNT. Drag or scroll horizontally; click any agent to open its trial dossier.
View
Phase
Status
del(17p) / TP53 thread
No agents match the current filters.
Tip: drag the timeline · click an agent for its trial dossier · toggle the del(17p) thread